Sale of Verne Global
During the period, the Company ran a competitive
sale process for the Verne Global group of companies
(which has operations in Iceland, Finland and the United
Kingdom).
As announced on 28 September 2023,
the Company received several non-binding offers for
a majority stake in Verne Global. The Company, with
the support of Goldman Sachs International (financial
adviser for the transaction), assessed the merits of the
non-binding offers for a majority stake to maximise
shareholder value. The Company concluded that a
sale of the Company’s entire stake in Verne Global
was in shareholders’ best interests because, amongst
other considerations, it provided an opportunity for
the Company to substantially deleverage its balance
sheet and provide the cash resources necessary for the
Company to strengthen its financial position, particularly
in light of Verne Global’s
significantly increased capital
expenditure pipeline that the Company was unable to
fund.
As announced on 15 March 2024, the Company
completed the Verne Transaction for an equity
purchase price of up to $575 million (approximately
£450 million*). Following completion of the Verne
Transaction, the Company received $415 million (£325.8
million) (the “Initial Purchase Price”). The completion
followed receipt of all applicable regulatory approvals
and the satisfaction of all conditions in line with the
previously communicated timetable. A further deferred
consideration of US$25 million (approximately £20
million**) which formed part of the purchase price has
now been received.
The purchase price also comprised a potential
Earn-Out payment of up to $135 million (approximately
£108 million**), which is payable subject to Verne
Global achieving run-rate EBITDA targets for the
financial year ending December 2026 (the
“Performance
Target”). The total Earn-Out will be payable if 100% of
the Performance Target is met and will be reduced on
a sliding scale with no Earn-Out being payable if Verne
Global does not achieve 80% of the Performance Target.
This target is as set in the business plan provided to all
potential purchasers at the time of the sale process.
The Investment Manager believes that Ardian’s own
value creation objectives are aligned with deploying the
requisite capital expenditures to enable Verne Global
to deliver in line with or close to the Performance
Target.
The Company also benefits from customary
protections to ensure Verne Global continues operating
and reporting substantially in line with existing practices,
including the provision of quarterly updates on its run-
rate EBITDA.
Following the completion of the Verne Transaction as
announced on 15 March 2024, the Initial Purchase Price
proceeds were used as follows:
•
£273.5* million was used for partial repayment of
the RCF (more details on this below);
•
c.£17 million to pay costs incurred in relation to
the Verne Transaction, including a contingency of
£1.6 million
***;
•
Around £12 million was retained to cover future
operational expenses of the Company if and when
required; and
•
Around £23 million was retained for prudent capital
management to cover possible future liabilities
arising from certain indemnification provisions made
in connection with the Verne Transaction.
Suspension of the Company’s dividend
In September 2023, at the time of considering the Q2
2023 dividend, the Board and Investment Manager
were mindful of the uncertainty around the timing of
the completion of the sale of Verne Global and were
conscious, that the persistence of a high interest rate
environment continued to weigh on the Company’s
liquidity position. Therefore it was agreed that a more
conservative approach to capital allocation was required
in the interest of the Company and its shareholders,
and, on 28 September 2023 the Board elected not to
declare the Q2 2023 dividend and withdrew its target
dividend of 6.0 pence per Ordinary Share for the
year ending 31 December 2023.
During the year, the
Company paid a total dividend of 3.0 pence per share:
1.5 pence was paid in March 2023 relating to the period
to 31 December 2022, and a further 1.5 pence per share
in June 2023 in relation to the period to 31 March 2023.
No further dividends have been declared for 2023.
*
GBP amounts based on a 1.28 USD/GBP exchange rate as of 13 March 2024.
**
GBP amounts based on a 1.25 USD/GBP exchange rate as of 25 April 2024.
***
It was agreed with the RCF lenders that £17 million would be set aside to pay costs arising from the Verne Transaction. This includes:.£1.0 million
for financing
arrangement costs related to the accordion facility for Verne Global and legal fees to implement the amendments to the RCF facility; £14.4 million for transaction
advisory services, including£5.8 million for
financial advice,
£5.8 million for legal advice, and £2.8 million forvendor due diligence, tax, and other advice and
expenses in relation to the Verne Transaction.
The remaining £1.6 million represents a contingency which has not yet been utilised and may be further used to
pay down the RCF..
£9.2 million of the above mentioned £17 million was incurred in the period-ended 31 December 2023, and £6.2 million was incurred post-
period end in 2024. The level of costs due to advisory fees incurred
for the Verne Transaction reflects
the transaction's complexity in contemplating different
transaction structures and executing the sale of three separate legal entities in three different jurisdictions.
Strategic Report
2023 Annual Report
|
17